PUBLIC COMPANY
saveNanoscope Therapeutics Inc
updated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Preclinical1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
- —Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
- —A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
- —Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
- phase2Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
- —Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT
- phase2Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that